Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

BIO-TECHNE (TECH) Inventory: 2010-2025

Historic Inventory for BIO-TECHNE (TECH) over the last 16 years, with Jun 2025 value amounting to $189.4 million.

  • BIO-TECHNE's Inventory rose 9.81% to $203.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $203.2 million, marking a year-over-year increase of 9.81%. This contributed to the annual value of $189.4 million for FY2025, which is 5.41% up from last year.
  • According to the latest figures from FY2025, BIO-TECHNE's Inventory is $189.4 million, which was up 5.41% from $179.7 million recorded in FY2024.
  • In the past 5 years, BIO-TECHNE's Inventory registered a high of $189.4 million during FY2025, and its lowest value of $116.7 million during FY2021.
  • Moreover, its 3-year median value for Inventory was $179.7 million (2024), whereas its average is $180.3 million.
  • Data for BIO-TECHNE's Inventory shows a peak YoY rose of 21.62% (in 2023) over the last 5 years.
  • Over the past 5 years, BIO-TECHNE's Inventory (Yearly) stood at $116.7 million in 2021, then increased by 20.88% to $141.1 million in 2022, then rose by 21.62% to $171.6 million in 2023, then rose by 4.72% to $179.7 million in 2024, then grew by 5.41% to $189.4 million in 2025.